CX3CL1/CX3CR1 in Alzheimer's Disease: A Target for Neuroprotection - Wikidata - wikimedia - TriplyDB

CX3CL1/CX3CR1 in Alzheimer's Disease: A Target for Neuroprotection

CX3CL1/CX3CR1 in Alzheimer's Disease: A Target for Neuroprotection

http://www.wikidata.org/entity/Q26739374

about

Association of the CX3CR1-V249I Variant with Neurofibrillary Pathology Progression in Late-Onset Alzheimer's Disease.Longitudinal chemokine profile expression in a blood-brain barrier model from Alzheimer transgenic versus wild-type mice.Bidirectional Microglia-Neuron Communication in Health and Disease Early Life Stress and Epigenetics in Late-onset Alzheimer's Dementia: A Systematic Review Decreased CX3CL1 Levels in the Cerebrospinal Fluid of Patients With Alzheimer's Disease Chemokine-Induced Macrophage Polarization in Inflammatory Conditions Differential chemokine expression under the control of peripheral blood mononuclear cells issued from Alzheimer's patients in a human blood brain barrier model

P2860

Q48361868-A9CA786A-C365-4FD4-A05B-D0F17EB621D1 Q55380454-F62D2F6C-F36D-4DE8-9F96-2EDF27B6064E Q57490780-D82E124D-B7A8-4F27-A3BA-1A72BE1DD5E5 Q58549216-F718DD43-5CC3-4106-9FB8-954278186963 Q58758801-2469B9C0-51AC-470C-A6F1-1B8AB5BC2A88 Q58758969-70F71DBB-4065-439C-A27A-7935702E6E24 Q58794404-61BF14F2-E575-4BC3-856C-9B7188837C15

P2860

CX3CL1/CX3CR1 in Alzheimer's Disease: A Target for Neuroprotection

http://www.wikidata.org/entity/Q26739374

description

2016 nî lūn-bûn

@nan

2016 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

name

CX3CL1/CX3CR1 in Alzheimer's Disease: A Target for Neuroprotection

@ast

CX3CL1/CX3CR1 in Alzheimer's Disease: A Target for Neuroprotection

@en

CX3CL1/CX3CR1 in Alzheimer's Disease: A Target for Neuroprotection

@nl

type

label

CX3CL1/CX3CR1 in Alzheimer's Disease: A Target for Neuroprotection

@ast

CX3CL1/CX3CR1 in Alzheimer's Disease: A Target for Neuroprotection

@en

CX3CL1/CX3CR1 in Alzheimer's Disease: A Target for Neuroprotection

@nl

prefLabel

CX3CL1/CX3CR1 in Alzheimer's Disease: A Target for Neuroprotection

@ast

CX3CL1/CX3CR1 in Alzheimer's Disease: A Target for Neuroprotection

@en

CX3CL1/CX3CR1 in Alzheimer's Disease: A Target for Neuroprotection

@nl

P1433

Q26739374-BFE32E28-749C-4CD1-87DA-B0B442AC96C8

P1476

Q26739374-220B2028-94CA-44CC-86EA-F5AEC6CA06C5

P2093

Q26739374-98C68D6C-FD3F-4389-B88F-8CF13D26A58A

Q26739374-F6FFBE16-02E4-4706-AB7B-D003A1141809

Q26739374-FDE93942-499E-4701-B071-90354CC7D8EA

P275

Q26739374-9A5E5F62-E0A0-4843-AA51-EC86A9ED54DB

P2860

Q26739374-033744FC-69D6-4968-87DB-D35F24A73D6E

Q26739374-0477C375-ED1C-465F-8359-9D49A6D01FB0

Q26739374-052FA3F5-CAA4-4B2A-B45B-4A6E72FA66AC

Q26739374-058D626F-BB23-4B4F-9D12-F6AE8C167A8A

Q26739374-06559B3D-2E7F-4C2A-B6B0-92D7B47DE48C

Q26739374-07C6EB2A-8617-45EB-8CF9-41BC50EF7E57

Q26739374-0A0B717B-6174-42A6-AF1B-382C3883E6DE

Q26739374-0B6511CA-2312-478F-BDA2-DF44BE540AAD

Q26739374-0F347EE1-F3F6-4077-80E6-331E612B0CE0

Q26739374-13F0ACB0-201E-4C90-ACF8-4031E94BC0D5

P304

Q26739374-975CAF00-829E-4A65-8182-3F64CCD9F4D9

P31

Q26739374-FFC101F5-E472-4B90-9A00-504312BC2E60

P3181

Q26739374-8FD35FC6-411A-493D-A094-56EC81EAECAF

P356

Q26739374-639CFEC2-4C88-421E-935F-66736F4F9987

P407

Q26739374-4293EAA9-DAC0-4FA1-AD3C-963D6AD4F505

P478

Q26739374-A8C7F4EC-0DF1-4B89-94B0-DF18663B03D9

P50

Q26739374-35F76A17-1CA0-4B17-88ED-AE73F81C2267

Q26739374-8200B057-DEBC-47ED-8B7B-1BB823099CBD

P5008

Q26739374-4B7220E0-4E0B-4FE6-84B1-8D87BD0E8C29

P577

Q26739374-6620E5CB-1B16-4B25-9C3E-AD9E80946E93

P698

Q26739374-302212D3-DB99-45F6-AC68-4E8EDA6AA05E

P921

Q26739374-3BECA903-6C64-4BCB-9BCC-80032C253D6C

Q26739374-574C3827-7E70-48CF-A3B7-A56C39F7D790

Q26739374-581089DB-58F6-4B88-805D-1444C3953AE8

Q26739374-C108A91F-FF6A-4D07-877E-2753245741C6

P932

Q26739374-EA8E5637-F0D2-4080-85F7-67BFFAF6F288

P3181

P356

P1433

BioMed Research International

P1476

CX3CL1/CX3CR1 in Alzheimer's Disease: A Target for Neuroprotection

@en

P2093

Juan Xu

http://www.w3.org/2001/XMLSchema#string

Peiqing Chen

http://www.w3.org/2001/XMLSchema#string

Yanjie Guo

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease

CX3CL1 is up-regulated in the rat hippocampus during memory-associated synaptic plasticity

Targeting TNF: a therapeutic strategy for Alzheimer's disease

Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival

Getting to NO Alzheimer's Disease: Neuroprotection versus Neurotoxicity Mediated by Nitric Oxide

Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain.

Depletion of microglia and inhibition of exosome synthesis halt tau propagation.

Amyloid-Beta Induced Changes in Vesicular Transport of BDNF in Hippocampal Neurons

Hydrogen sulfide inhibits the development of atherosclerosis with suppressing CX3CR1 and CX3CL1 expression

Does neuroinflammation fan the flame in neurodegenerative diseases?

P304

8090918

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

472943

http://www.w3.org/2001/XMLSchema#string

P356

10.1155/2016/8090918

http://www.w3.org/2001/XMLSchema#string

P407

P478

2016

http://www.w3.org/2001/XMLSchema#string

P50

P5008

P577

2016-06-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27429982

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

cell surface receptor

membrane proteins

P932

4939332

http://www.w3.org/2001/XMLSchema#string